Last reviewed · How we verify

Acetaminophen & Indomethacin — Competitive Intelligence Brief

Acetaminophen & Indomethacin (Acetaminophen & Indomethacin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic/Anti-inflammatory combination. Area: Pain Management.

marketed Analgesic/Anti-inflammatory combination COX-1, COX-2 (indomethacin); central nervous system analgesic pathways (acetaminophen) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Acetaminophen & Indomethacin (Acetaminophen & Indomethacin) — Queen's University. This combination reduces pain and inflammation through dual inhibition of cyclooxygenase (COX) enzymes and direct analgesic action.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Acetaminophen & Indomethacin TARGET Acetaminophen & Indomethacin Queen's University marketed Analgesic/Anti-inflammatory combination COX-1, COX-2 (indomethacin); central nervous system analgesic pathways (acetaminophen)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic/Anti-inflammatory combination class)

  1. Queen's University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Acetaminophen & Indomethacin — Competitive Intelligence Brief. https://druglandscape.com/ci/acetaminophen-indomethacin. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: